Comparative Pharmacology
Head-to-head clinical analysis: DECA DURABOLIN versus XTRENBO.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DECA DURABOLIN versus XTRENBO.
DECA-DURABOLIN vs XTRENBO
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nandrolone decanoate is an anabolic steroid that binds to androgen receptors, increasing protein synthesis and promoting muscle growth. It also stimulates erythropoietin production, increasing red blood cell mass.
XTRENBO (testosterone undecanoate) is an androgen receptor agonist. Testosterone binds to androgen receptors, activating gene transcription that leads to the development and maintenance of male secondary sexual characteristics. It also exerts anabolic effects.
Intramuscular injection of 100-200 mg every 1-3 weeks for anabolic effects; for replacement therapy, 50-100 mg every 2-4 weeks.
0.25 mg intramuscularly once daily
None Documented
None Documented
Terminal half-life of nandrolone decanoate is 4.3 hours for the decanoate ester, but the active metabolite nandrolone has a prolonged half-life of 6-7 days due to slow release from intramuscular depot and enterohepatic recirculation; clinical effects persist for 3-4 weeks.
12-18 hours (terminal), requiring twice-daily dosing for sustained serum concentrations.
Primarily renal (90% as metabolites, 5% unchanged); fecal elimination accounts for <5%.
Primarily renal (70%) as unchanged drug; 20% biliary/fecal; 10% metabolized to inactive glucuronides.
Category C
Category C
Anabolic Steroid
Anabolic Steroid